Skip to main content

Table 1 General characteristics and biochemical studies in both case and control groups and the related comparisons

From: Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients

Variable

control

case

P value

Age (y)

46.72 ± 15.89

43.68 ± 17.01

0.57

Weight (Kg)

70.89 ± 14.33

75.06 ± 22.11

0.51

Height (cm)

159.83 ± 10.4

163.47 ± 9.92

0.29

BMI (Kg/m2)

27.82 ± 3.53

27.75 ± 7.83

0.97

PTH (pg/ml)

57.97 ± 18.06

8.92 ± 4.38

< 0.001

Ca (mg/dl)

9.20 ± 0.46

7.98 ± 0.86

< 0.001

PO4(mg/dl)

3.82 ± 0.46

5.26 ± 0.93

< 0.001

ALP(IU/L)

148.22 ± 37.9

132.58 ± 40.69

0.23

1,25(OH)2D (pg/ml)

23.73 ± 17.90

30.57 ± 17.77

0.25

25 (OH)D (ng/ml)

33.56 ± 32.35

53.11 ± 40.71

0.11

FGF23 (pg/ml)

24.66 ± 17.73

47.88 ± 22.14

< 0.001

FE PO4(%)

15.77 ± 6.64

16.96 ± 11.40

0.70

  1. BMI Body mass index, FGF-23 Fibroblast Growth Factor 23, ALP Alkaline phosphatase, PO4 phosphorus, Ca Calcium, PTH Parathyroid Hormone, FE PO4 Fraction excretion of phosphorus